273 related articles for article (PubMed ID: 26849938)
1. Neurobehavioral effects of liraglutide and sitagliptin in experimental models.
Kamble M; Gupta R; Rehan HS; Gupta LK
Eur J Pharmacol; 2016 Mar; 774():64-70. PubMed ID: 26849938
[TBL] [Abstract][Full Text] [Related]
2. Effects of liraglutide on depressive behavior in a mouse depression model and cognition in the probe trial of Morris water maze test.
Seo MK; Jeong S; Seog DH; Lee JA; Lee JH; Lee Y; McIntyre RS; Park SW; Lee JG
J Affect Disord; 2023 Mar; 324():8-15. PubMed ID: 36566932
[TBL] [Abstract][Full Text] [Related]
3. Liraglutide prevents cognitive decline in a rat model of streptozotocin-induced diabetes independently from its peripheral metabolic effects.
Palleria C; Leo A; Andreozzi F; Citraro R; Iannone M; Spiga R; Sesti G; Constanti A; De Sarro G; Arturi F; Russo E
Behav Brain Res; 2017 Mar; 321():157-169. PubMed ID: 28062257
[TBL] [Abstract][Full Text] [Related]
4. Glucagon-like peptide-1 (GLP-1) receptor agonist prevents development of tolerance to anti-anxiety effect of ethanol and withdrawal-induced anxiety in rats.
Sharma AN; Pise A; Sharma JN; Shukla P
Metab Brain Dis; 2015 Jun; 30(3):719-30. PubMed ID: 25380665
[TBL] [Abstract][Full Text] [Related]
5. Glucagon-like peptide-1 (GLP-1) receptor agonism or DPP-4 inhibition does not accelerate neoplasia in carcinogen treated mice.
Kissow H; Hartmann B; Holst JJ; Viby NE; Hansen LS; Rosenkilde MM; Hare KJ; Poulsen SS
Regul Pept; 2012 Nov; 179(1-3):91-100. PubMed ID: 22989472
[TBL] [Abstract][Full Text] [Related]
6. Sitagliptin, a dipeptidyl peptidase-4 inhibitor, improves recognition memory, oxidative stress and hippocampal neurogenesis and upregulates key genes involved in cognitive decline.
Gault VA; Lennox R; Flatt PR
Diabetes Obes Metab; 2015 Apr; 17(4):403-13. PubMed ID: 25580570
[TBL] [Abstract][Full Text] [Related]
7. [Emotional Motivational Disorders in Rats as a Result of Diprotin A and Sitagliptin Administration in the First Postnatal Week].
Krupina NA; Khlebnikova NN; Orlova IN
Zh Vyssh Nerv Deiat Im I P Pavlova; 2016 May; 66(3):367-381. PubMed ID: 30695419
[TBL] [Abstract][Full Text] [Related]
8. β-Caryophyllene, a CB2 receptor agonist produces multiple behavioral changes relevant to anxiety and depression in mice.
Bahi A; Al Mansouri S; Al Memari E; Al Ameri M; Nurulain SM; Ojha S
Physiol Behav; 2014 Aug; 135():119-24. PubMed ID: 24930711
[TBL] [Abstract][Full Text] [Related]
9. Anxiolytic and antidepressant effects of ACPA and harmaline co-treatment.
Ebrahimi-Ghiri M; Nasehi M; Zarrindast MR
Behav Brain Res; 2019 May; 364():296-302. PubMed ID: 30797851
[TBL] [Abstract][Full Text] [Related]
10. Differential role of AMPA receptors in mouse tests of antidepressant and anxiolytic action.
Andreasen JT; Fitzpatrick CM; Larsen M; Skovgaard L; Nielsen SD; Clausen RP; Troelsen K; Pickering DS
Brain Res; 2015 Mar; 1601():117-26. PubMed ID: 25578259
[TBL] [Abstract][Full Text] [Related]
11. Glucagon-like peptide-1 (GLP-1) mediates the protective effects of dipeptidyl peptidase IV inhibition on pulmonary hypertension.
Wang J; Yu M; Xu J; Cheng Y; Li X; Wei G; Wang H; Kong H; Xie W
J Biomed Sci; 2019 Jan; 26(1):6. PubMed ID: 30634956
[TBL] [Abstract][Full Text] [Related]
12. Protective effects of forced exercise against nicotine-induced anxiety, depression and cognition impairment in rat.
Motaghinejad M; Fatima S; Karimian M; Ganji S
J Basic Clin Physiol Pharmacol; 2016 Jan; 27(1):19-27. PubMed ID: 26512426
[TBL] [Abstract][Full Text] [Related]
13. Glucagon-Like Peptide-1 Mediates the Protective Effect of the Dipeptidyl Peptidase IV Inhibitor on Renal Fibrosis via Reducing the Phenotypic Conversion of Renal Microvascular Cells in Monocrotaline-Treated Rats.
Xu J; Wang J; Cheng Y; Li X; He M; Zhu J; Han H; Wei G; Kong H; Xie W; Wang H; Zuo X
Biomed Res Int; 2018; 2018():1864107. PubMed ID: 29607314
[TBL] [Abstract][Full Text] [Related]
14. Amelioration of Scopolamine-Induced Amnesic, Anxiolytic and Antidepressant Effects of
Malik H; Javaid S; Fawad Rasool M; Samad N; Rizwan Ahamad S; Alqahtani F; Imran I
Medicina (Kaunas); 2020 Mar; 56(3):. PubMed ID: 32210162
[No Abstract] [Full Text] [Related]
15. Neurochemical modulation involved in the beneficial effect of liraglutide, GLP-1 agonist on PTZ kindling epilepsy-induced comorbidities in mice.
Koshal P; Kumar P
Mol Cell Biochem; 2016 Apr; 415(1-2):77-87. PubMed ID: 26965494
[TBL] [Abstract][Full Text] [Related]
16. Somatostatin receptor subtype 4 activation is involved in anxiety and depression-like behavior in mouse models.
Scheich B; Gaszner B; Kormos V; László K; Ádori C; Borbély É; Hajna Z; Tékus V; Bölcskei K; Ábrahám I; Pintér E; Szolcsányi J; Helyes Z
Neuropharmacology; 2016 Feb; 101():204-15. PubMed ID: 26387439
[TBL] [Abstract][Full Text] [Related]
17. Liraglutide versus sitagliptin for patients with type 2 diabetes who did not have adequate glycaemic control with metformin: a 26-week, randomised, parallel-group, open-label trial.
Pratley RE; Nauck M; Bailey T; Montanya E; Cuddihy R; Filetti S; Thomsen AB; Søndergaard RE; Davies M;
Lancet; 2010 Apr; 375(9724):1447-56. PubMed ID: 20417856
[TBL] [Abstract][Full Text] [Related]
18. Evaluation of two genetic animal models in behavioral tests of anxiety and depression.
Hinojosa FR; Spricigo L; Izídio GS; Brüske GR; Lopes DM; Ramos A
Behav Brain Res; 2006 Mar; 168(1):127-36. PubMed ID: 16324754
[TBL] [Abstract][Full Text] [Related]
19. Evaluation of the effects of liraglutide on the development of epilepsy and behavioural alterations in two animal models of epileptogenesis.
Citraro R; Iannone M; Leo A; De Caro C; Nesci V; Tallarico M; Abdalla K; Palma E; Arturi F; De Sarro G; Constanti A; Russo E
Brain Res Bull; 2019 Nov; 153():133-142. PubMed ID: 31470253
[TBL] [Abstract][Full Text] [Related]
20. Concurrent nociceptive stimulation impairs the anxiolytic effect of midazolam injected into the periaqueductal gray in mice.
Mendes-Gomes J; Nunes-de-Souza RL
Brain Res; 2005 Jun; 1047(1):97-104. PubMed ID: 15893297
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
